Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer

NCT00003516 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Prostate Cancer

Interventions

DRUG: Antineoplaston therapy (Atengenal + Astugenal)

Sponsor

Burzynski Research Institute